41
Views
6
CrossRef citations to date
0
Altmetric
Original Article

The Role of Ifosfamide in the Treatment of Lymphomas

Pages 433-441 | Received 30 Oct 1998, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Malcolm Lawson, Arthur Vasilaras, Annamarie De Vries, Peter MacTaggart & David Nicol. (2008) Urological implications of cyclophosphamide and ifosfamide. Scandinavian Journal of Urology and Nephrology 42:4, pages 309-317.
Read now

Articles from other publishers (5)

Byeong-Bae Park, Won Seog Kim, Hyeon Seok Eom, Jin Seok Kim, Young Yiul Lee, Suk Joong Oh, Dae Ho Lee & Cheolwon Suh. (2009) Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin’s lymphoma: a consortium for improving survival of lymphoma (CISL) trial. Investigational New Drugs 29:1, pages 154-160.
Crossref
G. Corazzelli, F. Russo, G. Capobianco, G. Marcacci, P. Della Cioppa & A. Pinto. (2006) Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study. Annals of Oncology 17, pages iv18-iv24.
Crossref
Saadettin Kilickap, Mustafa Cakar, Ibrahim K Onal, Abdurrahman Tufan, Hadim Akoglu, Sercan Aksoy, Mustafa Erman & Gulten Tekuzman. (2016) Nonconvulsive Status Epilepticus Due to Ifosfamide. Annals of Pharmacotherapy 40:2, pages 332-335.
Crossref
Yago Nieto. 2005. 163 203 .
Yago Nieto. 2003. 171 209 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.